Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Taiwan / NCT07160907
Recruiting Not applicable

The Impact of Elderly Simulation Experience on Aging Knowledge, Attitudes, Empathy, Communication Skills and Learning Satisfaction for Facility Care- Workers in Long-term Care Institutions : An Action Research and Effectiveness Evaluation

NCT07160907 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Tzu Chi University
Phase
Not applicable
Started
2025-10-01
Last updated
2025-09-08

Condition(s) studied

CareworkerEducation

Investigational drug(s) / intervention(s)

Ageing Simulation Experience Program

Ageing Simulation Experience Program: Ageing Simulation Experience Program is a structured training that includes a multimedia lecture, a hands-on aging simulation using the PengZu Suit, and a peer discussion. It aims to enhance care workers' aging knowledge, empathy, attitudes, and communication skills through experiential learning.

Study summary

This study aims to evaluate the effectiveness of an aging simulation experience course in enhancing the aging knowledge, care attitudes, empathy, communication skills, and learning satisfaction of care service personnel working in residential long-term care institutions.

Eligibility

Sex
ALL
Min age
20 Years
Max age
70 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Participants must be care workers currently employed at residential long-term care institutions in Eastern Taiwan, aged between 20 and 70 years. They must have at least one month of work experience in their current role, be literate, capable of completing written questionnaires, able to communicate in Mandarin or Taiwanese, and willing to provide informed consent to participate in the study. Exclusion Criteria: * Individuals will be excluded if they do not meet the above inclusion criteria, decline to participate or withdraw consent during the study, or are physically unable to safely engage in the aging simulation activity due to health or mobility limitations.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tzu Chi University Hualien City Taiwan Recruiting

More Tzu Chi University trials in Taiwan

FR-taVNS Tinnitus Tria Recruiting
The Effectiveness of Squat Exercise for Improving Pre-Sarcopenia in Order Adults Recruiting
Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT Recruiting

Other trials for the same condition

The Effectiveness of Gamified Scenario-based Teaching in Improving Nurses' Awareness and Confidence in Clinical Emergency Care Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07160907 on ClinicalTrials.gov ↗ ← All trials in Taiwan